CINRYZE

takeda canada inc🇨🇦 Health Canada

Approval Id: f1863af9074219a1
Drug Approval Canada Name: CINRYZE
Product Name: CINRYZE
Status: Dormant
Status Date: 2023-09-17
Original Market Date: 2016-03-08
Din: 02395371
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous
Schedule: Schedule D
Ahfs: 92:32.00
Atc Original: B06AC01 C1-INHIBITOR, PLASMA DERIVED
Atc Name: b 06 ac 01
Aig Number: 0152746001
Company Name: takeda canada inc
Company Address: 3800, 22 Adelaide Street West, Toronto, Ontario, Canada, M5H 4E3

C1 ESTERASE INHIBITOR (HUMAN)

500 UNIT / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f1863af9074219a1

Type

Standard